News
4d
Shareholders In ACADIA Pharmaceuticals (NASDAQ:ACAD) Should Look Beyond Earnings For The Full Story
ACADIA Pharmaceuticals Inc. ( NASDAQ:ACAD ) recently released a strong earnings report, and the market responded ...
As the U.S. market experiences a mix of record highs and tempered expectations due to recent inflation reports, investors are closely monitoring economic indicators that could influence Federal ...
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the First Trust NYSE Arca ...
Stockhead on MSN4d
Morgans spotlights nine healthcare stocks with upcoming catalysts
Morgan's Scott Power highlights nine ASX healthcare companies from the 2025 Bioshares Biotech Summit with catalysts over next ...
Detailed price information for Amylyx Pharmaceuticals Inc (AMLX-Q) from The Globe and Mail including charting and trades.
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
TipRanks on MSN5d
Stoke Therapeutics Advances RNA Medicine with Strong Q2 Results
Stoke Therapeutics ( ($STOK) ) has released its Q2 earnings. Here is a breakdown of the information Stoke Therapeutics presented to its investors.
Stockhead on MSN19h
Precision Points: When it comes to biotechs’ messaging, a lingering KISS goes a long way
Why Precision Funds Management's Dermot Woods takes a shine to biotechs that can explain their programs in simple terms.
After an extraordinary career with Acadia Broadcasting that has spanned nearly four decades, the president is retiring. In a press release issued by the company Friday, Chris Pearson says he is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback